Abstract
Chemotherapy is not specific. It differs fundamentally from hormone therapy which is directly dependent on the hormone sensitivity of the tumor. This lack of specificity depresses the mitotic activity of all rapidly multiplying normal cells such as those of the hemopoietic bone marrow and the epithelium of the gastrointestinal tract. The magnitude of this antimitotic activity on normal cells can be serious and is often unpredictable. The choice of methods of administration is dictated by the widespread nature of the disease. Isolated perfusion for recurrence in the breast area or a previously untreated primary lesion is of little value, as there is no major cannulable arterial supply to the breast and innominate or subclavian cannulation 21 is even too localized for the distribution of the disease. It might, however, be an adjunct to parenteral therapy when there is a concentration of metastases at a site or in an organ with
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
